Ulrich Schaudig
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Ulrich Schaudig has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
F. Scholz
Datamedical-consulting
1 shared publicationG. Richard
Universitätsklinikum Eppendorf
1 shared publicationJ. Ußmüller
Regensburg
1 shared publicationKais Al-Samir
1 shared publicationR.-C. Lerche
Universitätsklinikum Eppendorf
1 shared publication- Rainer Maas
Radiological Office Raboisen 38, Hamburg, Germany
1 shared publication
Latest Publications
- 1 August 2004
- Published by Springer Nature in Der Ophthalmologe
- Vol. 101 (8) , 785-793
OCT bei Makulaödem
- 1 August 2004
- Published by Springer Nature in Der Ophthalmologe
- Vol. 101 (8) , 785-793
OCT bei Makulaödem
- 1 May 2004
- Published by Springer Nature in Der Ophthalmologe
- Vol. 101 (5) , 461-465
Transpositionslappenplastiken zur Rekonstruktion von tiefen Defekten des medialen Lidwinkels
- 1 May 2004
- Published by Springer Nature in Der Ophthalmologe
- Vol. 101 (5) , 461-465
Transpositionslappenplastiken zur Rekonstruktion von tiefen Defekten des medialen Lidwinkels
- 1 January 2004
- Published by Swets & Zeitlinger Publishers in Orbit
- Vol. 23 (1) , 65-76
Upper and lower eyelid reconstruction for severe disfiguring necrobiotic xanthogranuloma
BACKGROUND Necrobiotic xanthogranuloma is a rare disease featuring generalized xanthomatous inflammatory skin lesions associated with paraproteinemia and possible lymphoproliferative diseases. Eyelid involvement can be unilateral or bilateral and ranges from minor xanthelasma-like lesions to severe ulcerative disease with consecutive keratitis and scleritis. CASE REPORT The authors report the case of a 67-year-old woman with extensive necrobiotic xanthogranuloma involving the eyelids, head and neck, anterior chest, and both upper and lower extremities. Periorbital involvement caused severe upper and lower lid ectropium with chronic conjunctival inflammation and unilateral exposure keratitis. During a persistent period of low disease activity, granulomatous lesions and scars were widely excised, lids partially shortened and large full-thickness skin grafts applied. Uninvolved parts of the upper arms had to serve as donor sites, as other possible donor sites were not available. After successful reconstructi...
- 1 January 2004
- Published by Swets & Zeitlinger Publishers in Orbit
- Vol. 23 (1) , 65-76
Upper and lower eyelid reconstruction for severe disfiguring necrobiotic xanthogranuloma
BACKGROUND Necrobiotic xanthogranuloma is a rare disease featuring generalized xanthomatous inflammatory skin lesions associated with paraproteinemia and possible lymphoproliferative diseases. Eyelid involvement can be unilateral or bilateral and ranges from minor xanthelasma-like lesions to severe ulcerative disease with consecutive keratitis and scleritis. CASE REPORT The authors report the case of a 67-year-old woman with extensive necrobiotic xanthogranuloma involving the eyelids, head and neck, anterior chest, and both upper and lower extremities. Periorbital involvement caused severe upper and lower lid ectropium with chronic conjunctival inflammation and unilateral exposure keratitis. During a persistent period of low disease activity, granulomatous lesions and scars were widely excised, lids partially shortened and large full-thickness skin grafts applied. Uninvolved parts of the upper arms had to serve as donor sites, as other possible donor sites were not available. After successful reconstructi...
- 19 September 2000
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 238 (9) , 733-737
The polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications
Background: The polyurethane nasolacrimal duct stent is used as an alternative to conventional techniques for treatment of lower tear duct obstruction. The aim of this study was to evaluate the clinical success rate after a follow-up of 2 years. Methods: Nasolacrimal duct stent implantation was attempted in 19 patients with nasolacrimal duct obstruction proven by digital substraction dacryocystography. The median age of the patients was 50 years, and the minimum duration of symptoms was 3 months. Patients were followed up 1 week, 6 months, 1 year and 2 years after the procedure. Results: Eighteen stents were implanted in 17 patients without surgical complications. All stents were proven to be patent at the end of the procedure. Success rate, defined as proportion of patients free of symptoms, was 66.6%, 55.5% and 50% after 1 week, 6 months and 1 year, respectively, and remained unchanged thereafter. Three stents had to be removed between 6 months and 2 years after implantation. Histological examination showed granulation tissue growing into the opening and obstructing the stent in one case. Conclusion: Implantation of a polyurethane nasolacrimal duct stent is an alternative to conventional techniques in lower tear duct obstruction. Its overall success rate is lower than that reported after conventional dacryocystorhinostomy, but the procedure is fast, safe and reversible. Refinement of the surface and stent design may improve results in the future.
- 19 September 2000
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 238 (9) , 733-737
The polyurethane nasolacrimal duct stent for lower tear duct obstruction: long-term success rate and complications
Background: The polyurethane nasolacrimal duct stent is used as an alternative to conventional techniques for treatment of lower tear duct obstruction. The aim of this study was to evaluate the clinical success rate after a follow-up of 2 years. Methods: Nasolacrimal duct stent implantation was attempted in 19 patients with nasolacrimal duct obstruction proven by digital substraction dacryocystography. The median age of the patients was 50 years, and the minimum duration of symptoms was 3 months. Patients were followed up 1 week, 6 months, 1 year and 2 years after the procedure. Results: Eighteen stents were implanted in 17 patients without surgical complications. All stents were proven to be patent at the end of the procedure. Success rate, defined as proportion of patients free of symptoms, was 66.6%, 55.5% and 50% after 1 week, 6 months and 1 year, respectively, and remained unchanged thereafter. Three stents had to be removed between 6 months and 2 years after implantation. Histological examination showed granulation tissue growing into the opening and obstructing the stent in one case. Conclusion: Implantation of a polyurethane nasolacrimal duct stent is an alternative to conventional techniques in lower tear duct obstruction. Its overall success rate is lower than that reported after conventional dacryocystorhinostomy, but the procedure is fast, safe and reversible. Refinement of the surface and stent design may improve results in the future.